Jennie W. Taylor, MD | Authors

Tailored Therapy in Diffuse Gliomas: Using Molecular Classifiers to Optimize Clinical Management

June 15, 2013

We review the current data regarding the prognostic and predictive value of IDH mutation and 1p/19q codeletion in gliomas. We also discuss possible management algorithms using these biomarkers to tailor surgical and adjuvant therapy for specific diffuse gliomas.